IDH305 not checked

Novartis

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
None yet
 
Trials
1 active
1 in total · 1 in the EU
Targets
 

What this is

How it works
How it works isn't classified yet
Tested for
Advanced Malignancies That Harbor IDHR132 Mutations
Main trialPhase 1
“A Phase I study of IDH305 in patients with advanced malignancies that harbor IDH1R132 mutations.”In the company’s words, NCT02381886 on ClinicalTrials.gov

Other drugs for Advanced Malignancies That Harbor IDHR132 Mutations

All 140 drugs for Advanced Malignancies That Harbor IDHR132 Mutations

Coming up0

No dates coming up.

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials1

TrialPhaseCompletesWhat it tests
Phase 1Active, not recruiting 7 Dec 2016 A Study of IDH305 in Patients With Advanced Malignancies That Harbor IDH1R132 Mutations
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow IDH305

Following is part of Solo: you see every change to IDH305 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in